Nom du produit:1-tert-Butyl 3-methyl 4-oxopiperidine-1,3-dicarboxylate

IUPAC Name:1-tert-butyl 3-methyl 4-oxopiperidine-1,3-dicarboxylate

CAS:161491-24-3
Formule moléculaire:C12H19NO5
Pureté:97%
Numéro de catalogue:CM101967
Poids moléculaire:257.29

Unité d'emballage Stock disponible Prix($) Quantité
CM101967-100g in stock Ǹƚ
CM101967-500g in stock ǟǟǎ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:161491-24-3
Formule moléculaire:C12H19NO5
Point de fusion:-
Code SMILES:O=C(N1CC(C(OC)=O)C(CC1)=O)OC(C)(C)C
Densité:
Numéro de catalogue:CM101967
Poids moléculaire:257.29
Point d'ébullition:350°C at 760 mmHg
N° Mdl:MFCD08752608
Stockage:Keep in inert atmosphere, store at 2-8°C.

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

Column Infos

Relacorilant
Corcept completes enrollment in phase 3 Gradient trial of Relacorilant in patients with Adrenal Cushing’s Syndrome. Cushing's disease or hypercortisolism is a rare endocrine disorder that occurs when a pituitary adenoma makes excessive cortisol. Cortisol exerts its functions by binding to the glucocorticoid receptor (GR).
Relacorilant is a selective glucocorticoid receptor modulator (SGRM) in clinical development to prevent the effects of high cortisol. Relacorilant is being studied in various serious disorders, including ovarian, adrenal and prostate cancer and Cushing’s syndrome.

Related Products